Proteome Analysis Identified the PPARγ Ligand 15d-Pgj2 as a Novel Drug Inhibiting Melanoma Progression and Interfering With Tumor-Stroma Interaction

PLoS ONE - United States
doi 10.1371/journal.pone.0046103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

15-Deoxy-Δ12,14-Pgj2: Endogenous PPARγ Ligand or Minor Eicosanoid Degradation Product?

Journal of Clinical Investigation
Medicine
2003English

Biosynthesis of 15-Deoxy-Δ12,14-Pgj2 and the Ligation of PPARγ

Journal of Clinical Investigation
Medicine
2003English

Circulating Tumor Cells and Melanoma Progression

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

PPARγ Ligands Inhibit Primary Tumor Growth and Metastasis by Inhibiting Angiogenesis

Journal of Clinical Investigation
Medicine
2002English

Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering With HSP90-EGFR Interaction and Downstream Signaling Pathways

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

CDK5 Is a Novel Regulatory Protein in PPARγ Ligand-Induced Antiproliferation

International Journal of Oncology
Cancer ResearchOncology
2006English

Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2018English

Tumor Stroma–targeted Antibody-Drug Conjugate Triggers Localized Anticancer Drug Release

Journal of Clinical Investigation
Medicine
2018English

CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy